Evidence map›Paper›PMID 25562646›Full record

ReviewAnnual review of pharmacology and toxicology2015

Constellation pharmacology: a new paradigm for drug discovery.

Russell W Teichert, Eric W Schmidt, Baldomero M Olivera

Abstract readReview
In one paragraph

Review in Annual review of pharmacology and toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. An N-Terminally Elongated Peptide From Conus rolani Defines a New Class of Ribbon α-Conotoxins Targeting Muscle nAChRs.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Article
  3. Macrocycles of Saxitoxin: Insights into the Structure of Zetekitoxin AB.Chembiochem : a European journal of chemical biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chronicling changes in the somatosensory neurons after peripheral nerve injury.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. An integrative approach to the facile functional classification of dorsal root ganglion neuronal subclasses.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Russell W TeichertDepartment of Biology and.
Eric W Schmidt
Baldomero M Olivera

Funding

Venoms, Biological Resources, Molecular BiologyP01GM048677 · NIGMS · UNIVERSITY OF UTAH · PI BANDYOPADHYAY, PRADIP K · 1993 to 2018
$32.2M
Diverse Drug Lead Compounds from Bacterial Symbionts in Philippine MollusksU19TW008163 · FIC · UNIVERSITY OF UTAH · PI HAYGOOD, MARGO GENEVIEVE · 2014 to 2018
$5.2M
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusksU01TW008163 · FIC · OREGON HEALTH & SCIENCE UNIVERSITY · PI HAYGOOD, MARGO GENEVIEVE · 2008 to 2013
$4.3M
FIC NIH HHS U01 TW008163FIC NIH HHS U01TW008163FIC NIH HHS U19 TW008163NIGMS NIH HHS GM48677NIGMS NIH HHS P01 GM048677
6 · The paper itself

Abstract

Constellation pharmacology is a cell-based high-content phenotypic-screening platform that utilizes subtype-selective pharmacological agents to elucidate the cell-specific combinations (constellations) of key signaling proteins that define specific cell types. Heterogeneous populations of native cells, in which the different individual cell types have been identified and characterized, are the foundation for this screening platform. Constellation pharmacology is useful for screening small molecules or for deconvoluting complex mixtures of biologically active natural products. This platform has been used to purify natural products and discover their molecular mechanisms. In the ongoing development of constellation pharmacology, there is a positive feedback loop between the pharmacological characterization of cell types and screening for new drug candidates. As constellation pharmacology is used to discover compounds with novel targeting-selectivity profiles, those new compounds then further help to elucidate the constellations of specific cell types, thereby increasing the content of this high-content platform.

Indexed as

AnimalsDrug DiscoveryHigh-Throughput Screening AssaysHumansMolecular Targeted TherapyNeural PathwaysNeuronsPeptidesPharmacologySignal TransductionVenomsPeptidesVenomsconotoxinconstellation pharmacologydorsal root gangliahigh-content screensomatosensory neuron

Identifiers

PMID25562646
PMCPMC4501256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.